[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Erectile Dysfunction Treatment Drugs Market Size, Status and Forecast 2020-2026

September 2020 | 94 pages | ID: CF4FA293A9F8EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Erectile Dysfunction Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Erectile Dysfunction Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • Pfizer Inc.
  • Dong-A Pharmaceutical Co. Ltd
  • Vivus, Inc.
  • Meda Pharmaceuticals
  • Bayer AG
  • Johnson & Johnson Services
  • Apricus Biosciences
  • Eli Lilly
Market segment by Type, the product can be split into
  • Phosphodiesterase Type 5 Inhibitors
  • Prostaglandin E1
Market segment by Application, split into
  • Hospitals
  • Clinic
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Erectile Dysfunction Treatment Drugs status, future forecast, growth opportunity, key market and key players.
  • To present the Erectile Dysfunction Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Erectile Dysfunction Treatment Drugs are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Erectile Dysfunction Treatment Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Phosphodiesterase Type 5 Inhibitors
  1.4.3 Prostaglandin E1
1.5 Market by Application
  1.5.1 Global Erectile Dysfunction Treatment Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Erectile Dysfunction Treatment Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Erectile Dysfunction Treatment Drugs Industry
    1.6.1.1 Erectile Dysfunction Treatment Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Erectile Dysfunction Treatment Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Erectile Dysfunction Treatment Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Erectile Dysfunction Treatment Drugs Market Perspective (2015-2026)
2.2 Erectile Dysfunction Treatment Drugs Growth Trends by Regions
  2.2.1 Erectile Dysfunction Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Erectile Dysfunction Treatment Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Erectile Dysfunction Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Erectile Dysfunction Treatment Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Erectile Dysfunction Treatment Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Erectile Dysfunction Treatment Drugs Players by Market Size
  3.1.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue (2015-2020)
  3.1.2 Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Erectile Dysfunction Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio
  3.2.1 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Treatment Drugs Revenue in 2019
3.3 Erectile Dysfunction Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Erectile Dysfunction Treatment Drugs Product Solution and Service
3.5 Date of Enter into Erectile Dysfunction Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Type (2021-2026)

5 ERECTILE DYSFUNCTION TREATMENT DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
6.2 Erectile Dysfunction Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
7.2 Erectile Dysfunction Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
8.2 Erectile Dysfunction Treatment Drugs Key Players in China (2019-2020)
8.3 China Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
8.4 China Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
9.2 Erectile Dysfunction Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
10.2 Erectile Dysfunction Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
11.2 Erectile Dysfunction Treatment Drugs Key Players in India (2019-2020)
11.3 India Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
11.4 India Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Erectile Dysfunction Treatment Drugs Market Size (2015-2020)
12.2 Erectile Dysfunction Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer Inc.
  13.1.1 Pfizer Inc. Company Details
  13.1.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Introduction
  13.1.4 Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020))
  13.1.5 Pfizer Inc. Recent Development
13.2 Dong-A Pharmaceutical Co. Ltd
  13.2.1 Dong-A Pharmaceutical Co. Ltd Company Details
  13.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview and Its Total Revenue
  13.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Introduction
  13.2.4 Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.2.5 Dong-A Pharmaceutical Co. Ltd Recent Development
13.3 Vivus, Inc.
  13.3.1 Vivus, Inc. Company Details
  13.3.2 Vivus, Inc. Business Overview and Its Total Revenue
  13.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Introduction
  13.3.4 Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.3.5 Vivus, Inc. Recent Development
13.4 Meda Pharmaceuticals
  13.4.1 Meda Pharmaceuticals Company Details
  13.4.2 Meda Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Introduction
  13.4.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.4.5 Meda Pharmaceuticals Recent Development
13.5 Bayer AG
  13.5.1 Bayer AG Company Details
  13.5.2 Bayer AG Business Overview and Its Total Revenue
  13.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Introduction
  13.5.4 Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.5.5 Bayer AG Recent Development
13.6 Johnson & Johnson Services
  13.6.1 Johnson & Johnson Services Company Details
  13.6.2 Johnson & Johnson Services Business Overview and Its Total Revenue
  13.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Introduction
  13.6.4 Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.6.5 Johnson & Johnson Services Recent Development
13.7 Apricus Biosciences
  13.7.1 Apricus Biosciences Company Details
  13.7.2 Apricus Biosciences Business Overview and Its Total Revenue
  13.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Introduction
  13.7.4 Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.7.5 Apricus Biosciences Recent Development
13.8 Eli Lilly
  13.8.1 Eli Lilly Company Details
  13.8.2 Eli Lilly Business Overview and Its Total Revenue
  13.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Introduction
  13.8.4 Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020)
  13.8.5 Eli Lilly Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Erectile Dysfunction Treatment Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Erectile Dysfunction Treatment Drugs Revenue
Table 3. Ranking of Global Top Erectile Dysfunction Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Phosphodiesterase Type 5 Inhibitors
Table 6. Key Players of Prostaglandin E1
Table 7. COVID-19 Impact Global Market: (Four Erectile Dysfunction Treatment Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Erectile Dysfunction Treatment Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Erectile Dysfunction Treatment Drugs Players to Combat Covid-19 Impact
Table 12. Global Erectile Dysfunction Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Erectile Dysfunction Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Erectile Dysfunction Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Erectile Dysfunction Treatment Drugs Market Share by Regions (2015-2020)
Table 16. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Erectile Dysfunction Treatment Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Erectile Dysfunction Treatment Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Erectile Dysfunction Treatment Drugs Players
Table 23. Global Erectile Dysfunction Treatment Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Erectile Dysfunction Treatment Drugs Market Share by Players (2015-2020)
Table 25. Global Top Erectile Dysfunction Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Treatment Drugs as of 2019)
Table 26. Global Erectile Dysfunction Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Erectile Dysfunction Treatment Drugs Product Solution and Service
Table 29. Date of Enter into Erectile Dysfunction Treatment Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Erectile Dysfunction Treatment Drugs Market Size Share by Type (2015-2020)
Table 33. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Erectile Dysfunction Treatment Drugs Market Size Share by Application (2015-2020)
Table 35. Global Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Erectile Dysfunction Treatment Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 39. North America Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 41. North America Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 45. Europe Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 47. Europe Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 51. China Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 53. China Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 57. Japan Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 59. Japan Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 63. Southeast Asia Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 69. India Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 71. India Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Erectile Dysfunction Treatment Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Erectile Dysfunction Treatment Drugs Market Share (2019-2020)
Table 75. Central & South America Erectile Dysfunction Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Erectile Dysfunction Treatment Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Erectile Dysfunction Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Erectile Dysfunction Treatment Drugs Market Share by Application (2015-2020)
Table 79. Pfizer Inc. Company Details
Table 80. Pfizer Inc. Business Overview
Table 81. Pfizer Inc. Product
Table 82. Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 83. Pfizer Inc. Recent Development
Table 84. Dong-A Pharmaceutical Co. Ltd Company Details
Table 85. Dong-A Pharmaceutical Co. Ltd Business Overview
Table 86. Dong-A Pharmaceutical Co. Ltd Product
Table 87. Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 88. Dong-A Pharmaceutical Co. Ltd Recent Development
Table 89. Vivus, Inc. Company Details
Table 90. Vivus, Inc. Business Overview
Table 91. Vivus, Inc. Product
Table 92. Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 93. Vivus, Inc. Recent Development
Table 94. Meda Pharmaceuticals Company Details
Table 95. Meda Pharmaceuticals Business Overview
Table 96. Meda Pharmaceuticals Product
Table 97. Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 98. Meda Pharmaceuticals Recent Development
Table 99. Bayer AG Company Details
Table 100. Bayer AG Business Overview
Table 101. Bayer AG Product
Table 102. Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 103. Bayer AG Recent Development
Table 104. Johnson & Johnson Services Company Details
Table 105. Johnson & Johnson Services Business Overview
Table 106. Johnson & Johnson Services Product
Table 107. Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 108. Johnson & Johnson Services Recent Development
Table 109. Apricus Biosciences Company Details
Table 110. Apricus Biosciences Business Overview
Table 111. Apricus Biosciences Product
Table 112. Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 113. Apricus Biosciences Recent Development
Table 114. Eli Lilly Business Overview
Table 115. Eli Lilly Product
Table 116. Eli Lilly Company Details
Table 117. Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2015-2020) (Million US$)
Table 118. Eli Lilly Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Erectile Dysfunction Treatment Drugs Market Share by Type: 2020 VS 2026
Figure 2. Phosphodiesterase Type 5 Inhibitors Features
Figure 3. Prostaglandin E1 Features
Figure 4. Global Erectile Dysfunction Treatment Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Erectile Dysfunction Treatment Drugs Report Years Considered
Figure 9. Global Erectile Dysfunction Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Erectile Dysfunction Treatment Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Erectile Dysfunction Treatment Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Erectile Dysfunction Treatment Drugs Market Share by Players in 2019
Figure 14. Global Top Erectile Dysfunction Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Treatment Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Erectile Dysfunction Treatment Drugs Revenue in 2019
Figure 16. North America Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Inc. Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 25. Dong-A Pharmaceutical Co. Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Dong-A Pharmaceutical Co. Ltd Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 27. Vivus, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Vivus, Inc. Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 29. Meda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Meda Pharmaceuticals Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 31. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bayer AG Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 33. Johnson & Johnson Services Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Johnson & Johnson Services Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 35. Apricus Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Apricus Biosciences Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 37. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Eli Lilly Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed


More Publications